ClinConnect ClinConnect Logo
Search / Trial NCT06323434

Spinal CSF Leaks in Chronic Subdural Hematoma

Launched by UNIVERSITY OF FREIBURG · Mar 14, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Spinal Csf Leak Spontaneous Intracranial Hypotension Csf Venous Fistula

ClinConnect Summary

This clinical trial is studying a condition called chronic subdural hematoma (cSDH), which is a type of bleeding in the brain that often affects older adults. Researchers want to find out how common spinal cerebrospinal fluid (CSF) leaks are in patients with cSDH. These leaks can lead to serious complications, including the cSDH itself, but they are often not diagnosed. The goal of the study is to gather more information to help doctors better identify and treat these leaks, as treatment can differ significantly based on whether a leak is present.

To participate in this trial, individuals must be 18 years or older and have imaging results showing cSDH. Those with certain conditions that prevent them from undergoing an MRI or those who have had previous treatments for cSDH may not be eligible. Participants will receive standard treatment and diagnostic tests, and their data will be collected to understand how many have spinal CSF leaks and what types are present. This information is crucial for improving care for patients with this condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Chronic subdural hematoma on imaging (CT/MRI)
  • 2. Age: 18 years or older
  • 3. Informed consent
  • Exclusion Criteria:
  • 1. General contraindications for MRI examination (e.g., pacemaker wearers, implanted insulin, or pain pump, neurostimulator, etc.)
  • 2. Recurrent chronic subdural hematoma and previously performed diagnostics and treatment in compliance to the current cSDH SOP
  • 3. Severe brain injury, acute subdural hematoma, epidural hematoma, subarachnoid hemorrhage

About University Of Freiburg

The University of Freiburg, a prestigious institution located in Germany, is renowned for its commitment to advancing medical research and education. As a leading academic center, it fosters innovation through interdisciplinary collaboration, leveraging its extensive expertise in various fields of healthcare. The university actively sponsors clinical trials aimed at enhancing patient outcomes and advancing scientific knowledge. With a strong focus on ethical standards and rigorous methodologies, the University of Freiburg is dedicated to contributing to the development of novel therapies and improving public health through its research initiatives.

Locations

Freiburg, , Germany

Freiburg, Baden Württemberg, Germany

Patients applied

0 patients applied

Trial Officials

Jürgen Beck, Prof.

Principal Investigator

Department of Neurosurgery, Medical Center, University of Freiburg

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported